TAMAI Hayato | Hiroshima University Hospital
スポンサーリンク
概要
Hiroshima University Hospital | 論文
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Current and future perspectives on the TARGET system : the registration system for Glivec^【○!R】 established by the JSH
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- The pharmacodynamic effect of omeprazole 10mg and 20mg once daily in patients with nonerosive reflux disease in Japan
- EVALUATION OF THE CLINICAL OUTCOMES ASSOCIATED WITH EXERA II AND LUCERA ENDOSCOPES